Zhe Wang
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Lipids, and Metabolism
- Molecular Biology top 5%
- RNA modifications and cancer
- Circular RNAs in diseases
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
Papers in
-
- RNA modifications and cancer 29
- Circular RNAs in diseases 13
-
- Cancer-related molecular mechanisms research 45
- MicroRNA in disease regulation 17
- Cancer, Lipids, and Metabolism 10
- Co-authors
- Yiqun Xia (2 shared papers)Xing Niu (2 shared papers)Shulin Yang (2 shared papers)Peng Zou (2 shared papers)Guang Liang (2 shared papers)Hao Chen (3 shared papers)Hao Wu (3 shared papers)Wei Chong (3 shared papers)
- Journals
- Frontiers in Pharmacology (5 papers)Frontiers in Immunology (5 papers)Cancer Letters (4 papers)Frontiers in Oncology (4 papers)Scientific Reports (4 papers)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Zhe Wang
186 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 137
- Cancer Research 1000
- Molecular Biology 1.6k
- Oncology 530
- Molecular Medicine 94
- Pulmonary and Respiratory Medicine 528
Countries citing papers authored by Zhe Wang
This map shows the geographic impact of Zhe Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhe Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhe Wang more than expected).
Fields of papers citing papers by Zhe Wang
This network shows the impact of papers produced by Zhe Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhe Wang. The network helps show where Zhe Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhe Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 198 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 169 | |
| 2 | 2015 | 121 | |
| 3 | 2016 | 109 | |
| 4 | 2013 | 77 | |
| 5 | 2017 | 74 | |
| 6 | 2019 | 55 | |
| 7 | 2017 | 54 | |
| 8 | 2007 | 52 | |
| 9 | 2023 | 47 | |
| 10 | 2021 | 46 | |
| 11 | 2014 | 45 | |
| 12 | 2015 | 41 | |
| 13 | 2016 | 39 | |
| 14 | 2023 | 38 | |
| 15 | 2018 | 38 | |
| 16 | 2017 | 38 | |
| 17 | 2023 | 37 | |
| 18 | 2018 | 37 | |
| 19 | 2014 | 36 | |
| 20 | 2013 | 36 |
About Zhe Wang
Zhe Wang is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Surgery, having authored 198 papers that have together received 3.0k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (45 papers), RNA modifications and cancer (29 papers), Ferroptosis and cancer prognosis (28 papers), MicroRNA in disease regulation (17 papers), Circular RNAs in diseases (13 papers), Cancer, Lipids, and Metabolism (10 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Sarcoma Diagnosis and Treatment (8 papers). The work is most often cited by research in Cancer Research (1000 citations), Molecular Biology (1.6k citations), Oncology (530 citations), Molecular Medicine (94 citations) and Pulmonary and Respiratory Medicine (528 citations). Zhe Wang has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Yiqun Xia, Xing Niu, Shulin Yang, Peng Zou, Guang Liang, Hao Chen, Hao Wu, Wei Chong, Liang Shang and Yang Liu. Their work appears in journals such as Frontiers in Pharmacology, Frontiers in Immunology, Cancer Letters, Frontiers in Oncology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.